Synbionik

Risk score

57
Large logo of Synbionik

Headquarters

Flag of GermanyGermany

Synbionik is dedicated to developing and manufacturing genetically modified microorganisms and corresponding bioreactor systems for the synthesis of chemical compounds. This innovative biosynthetic method offers significant cost, purity, and sustainability benefits compared to traditional production or extraction techniques. In addition, Synbionik is fully committed to leveraging advanced laboratory automation technologies to achieve substantial productivity advantages, establishing the company as an early adopter in Europe. The company's primary focus is on the biosynthetic production of cannabinoids, with a particular emphasis on cannabidiol (CBD), cannabigerol (CBG), and tetrahydrocannabinol.